← back to search

Michael T. Yin

Columbia University Irving Medical Center · US
Area of research
Emergency Medicine · Infectious Diseases
Research interest
Research interests include HIV-related health complications and treatments, HIV Research and Treatment, HIV/AIDS Research and Interventions, and Bone and Joint Diseases.
h-index
53
citations
13,675
works
310
NIH funding
primary concept
Medicine
email

Recent publications

Overlapping Clinical Presentation of Long COVID and Postacute COVID-19 Vaccination Syndrome: Phenotypes, Severity, and Biomarkers.
2026cited by 0position: contributordoi
Evaluation by dental professionals of an artificial intelligence-based application to measure alveolar bone loss.
2025cited by 3position: contributordoi
Association Between Inpatient Medication Treatment for Opioid Use Disorder and Reduced One-Year All-Cause Mortality in Patients With Invasive Bacterial Infections.
2025cited by 1position: contributordoi
A First-in-Class Dual Degrader of Bcl-2/Bcl-xL Reverses HIV Latency and Minimizes Ex Vivo Reservoirs from Patients.
2025cited by 0position: contributordoi
Distinct CD8 <sup>+</sup> T-cell types Associated with COVID-19 Severity in Unvaccinated HLA-A2 <sup>+</sup> Patients
2025cited by 0position: contributordoi
HepB-CpG vs HepB-Alum Vaccine in People With HIV and Prior Vaccine Nonresponse
JAMA 2024cited by 35position: middledoi
A point-of-care tenofovir urine test improves accuracy of self-reported preexposure prophylaxis adherence and increases condomless sex reporting among young women
AIDS 2024cited by 7position: middledoi
Postmenopausal women with HIV have increased tooth loss.
2024cited by 5position: contributordoi
Evaluation of the mandibular condylar bone microarchitecture in people living with HIV.
2024cited by 1position: contributordoi
Enabling a Learning Public Health System: Enhanced Surveillance of HIV and Other Sexually Transmitted Infections
2024cited by 0position: contributordoi
A population pharmacokinetic model of polymyxin B based on prospective clinical data to inform dosing in hospitalized patients.
2023cited by 20position: contributordoi
Assessing the contributions of modifiable risk factors to serious falls and fragility fractures among older persons living with HIV.
2023cited by 17position: contributordoi
The Long-Acting Cabotegravir Tail as an Implementation Challenge: Planning for Safe Discontinuation.
2023cited by 10position: contributordoi
Detection of SARS-CoV-2 IgG antibodies and inflammatory cytokines in saliva-a pilot study.
2023cited by 7position: contributordoi
Ideal cardiovascular health, biomarkers, and coronary artery disease in persons with HIV.
2023cited by 7position: contributordoi
Depression and PrEP uptake, interruption, and adherence among young women in Uganda
AIDS Care 2023cited by 5position: middledoi
Gut microbiota and plasma metabolites associated with bone mineral density in women with or at risk of HIV infection.
2023cited by 5position: contributordoi
Menopausal Hormone Therapy and Subclinical Cardiovascular Disease in Women With and Without Human Immunodeficiency Virus.
2023cited by 5position: contributordoi
Depression and PrEP uptake, interruption, and adherence among young women in Uganda.
2023cited by 5position: contributordoi
Disclosure to South African children about their own HIV status over time.
2023cited by 5position: contributordoi
Associations of Muscle Density and Area With Coronary Artery Plaque and Physical Function.
2023cited by 4position: contributordoi
Performance of a modified fracture risk assessment tool for fragility fracture prediction among older veterans living with HIV.
2023cited by 3position: contributordoi
Systemic exposure to hydroxychloroquine and its relationship with outcome in severely ill COVID-19 patients in New York City.
2023cited by 3position: contributordoi
Microbiota in the oral cavity of school-age children with HIV who started antiretroviral therapy at young ages in South Africa.
2023cited by 3position: contributordoi
The effect of daily oral PrEP use during pregnancy on bone mineral density among adolescent girls and young women in Uganda.
2023cited by 2position: contributordoi
Using a Health Information Exchange to Characterize Changes in HIV Viral Load Suppression and Disparities During the COVID-19 Pandemic in New York City.
2023cited by 1position: contributordoi
Deep Learning Approach to Measure Alveolar Bone Loss After COVID-19
2023cited by 0position: contributordoi
Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2.
2022cited by 1,172position: contributordoi
Antibody evasion properties of SARS-CoV-2 Omicron sublineages.
2022cited by 726position: contributordoi
Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5.
2022cited by 699position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Lihong Liu · First Hospital of Lanzhou University15 papers (2020–2022) · 12 papers (2022–2026)David D. Ho · Columbia University Vagelos College of Physicians and Surgeons10 papers (2020–2022)Yicheng Guo · Ten Chen Hospital10 papers (2021–2022)Manoj S. Nair · Confluence Life Sciences (United States)9 papers (2020–2022)Peter D. Kwong · National Institutes of Health7 papers (2020–2022) · 7 papers (2020–2024)Sho Iketani · Royal College of Physicians7 papers (2021–2025) · 7 papers (2020–2022)Jason Zucker · Presbyterian Hospital7 papers (2020–2024)Zizhang Sheng · Aaron Diamond AIDS Research Center6 papers (2020–2025)Qian Wang · Army Medical University6 papers (2020–2022)Yaoxing Huang · Longgang Central Hospital6 papers (2020–2022)Pengfei Wang · Chinese Research Academy of Environmental Sciences6 papers (2020–2021)Michael Plankey · Georgetown University4 papers (2015–2021)Kwok‐Yung Yuen · TSC Alliance4 papers (2020–2022)Hector Bolívar · University of Miami4 papers (2012–2021)Phyllis C. Tien · University Hospital and Clinics4 papers (2017–2021)Edgar T. Overton · AIDS Clinical Trials Group4 papers (2018–2023)Amy C. Justice · Yale University3 papers (2013–2019)